Elicio Therapeutics Investor Relations Material
Latest events
Status Update
Elicio Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Elicio Therapeutics Inc
Access all reports
Elicio Therapeutics Inc. is a biotechnology company focused on developing immunotherapies for the treatment of cancer and infectious diseases. The company specializes in AMP (Amphiphile) platform technology, designed to enhance the delivery of cancer vaccines and immunomodulators to the lymphatic system, improving immune response. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ELTX
Country
🇺🇸 United States